These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9349421)

  • 21. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
    Streilein JW; Niederkorn JY
    J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of surface HLA-A,B,C molecules in tumour immunity.
    Möller P; Hämmerling GJ
    Cancer Surv; 1992; 13():101-27. PubMed ID: 1423320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Potential endogenous immunological self-protection of uveal melanoma by indoleamine 2,3-dioxygenase].
    Beutelspacher SC; Serbecic N
    Klin Monbl Augenheilkd; 2008 Aug; 225(8):703-7. PubMed ID: 18712654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition of shared melanoma antigen by HLA-A2-restricted cytolytic T cell clones derived from human tumor-infiltrating lymphocytes.
    Viret C; Davodeau F; Guilloux Y; Bignon JD; Semana G; Breathnach R; Jotereau F
    Eur J Immunol; 1993 Jan; 23(1):141-6. PubMed ID: 8419164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of immune responses in the eradication of IL-1 alpha gene-transduced tumour cells: mechanisms of tumour rejection and immunotherapeutical implications.
    Apte RN; Douvdevani A; Zoller M; White RM; Dvorkin T; Shimoni N; Huleihel M; Fima E; Hacham M; Voronov E
    Folia Biol (Praha); 1994; 40(1-2):1-18. PubMed ID: 7958060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
    Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
    Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH; Gurish MF; Daynes RA
    Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenovirus-mediated gene transfer in canine eyes: a preclinical study for gene therapy of human uveal melanoma.
    Andrawiss M; Maron A; Beltran W; Opolon P; Connault E; Griscelli F; Yeh P; Perricaudet M; Devauchelle P
    J Gene Med; 2001; 3(3):228-39. PubMed ID: 11437328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
    Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the minimum requirements for in vitro "cure" of tumor cells by cytotoxic T lymphocytes.
    Miki S; Ksander B; Streilein JW
    Reg Immunol; 1992; 4(6):352-62. PubMed ID: 1297406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes. Possible mechanisms for immunotherapeutic failures.
    Topalian SL; Kasid A; Rosenberg SA
    J Immunol; 1990 Jun; 144(11):4487-95. PubMed ID: 2160503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunologic evaluation of spontaneous regression of an intraocular murine melanoma.
    Knisely TL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):247-57. PubMed ID: 2154414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4+ T-cell-dependent tumour rejection in an immune-privileged environment requires macrophages.
    Dace DS; Chen PW; Niederkorn JY
    Immunology; 2008 Mar; 123(3):367-77. PubMed ID: 17944931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunology of intraocular tumors.
    Niederkorn JY; Wang S
    Ocul Immunol Inflamm; 2005 Feb; 13(1):105-10. PubMed ID: 15835077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells.
    Repp AC; Mayhew ES; Apte S; Niederkorn JY
    J Immunol; 2000 Jul; 165(2):710-5. PubMed ID: 10878343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spontaneous cellular and humoral tumor antigen responses in patients with uveal melanoma.
    Triozzi PL; Aldrich W; Crabb JW; Singh AD
    Melanoma Res; 2015 Dec; 25(6):510-8. PubMed ID: 26397048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enucleation-induced metastasis of intraocular melanomas in mice.
    Niederkorn JY
    Ophthalmology; 1984 Jun; 91(6):692-700. PubMed ID: 6462628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aqueous immune mediators in malignant uveal melanomas in comparison to benign pigmented intraocular tumors.
    Usui Y; Tsubota K; Agawa T; Ueda S; Umazume K; Okunuki Y; Kezuka T; Yamakawa N; Goto H
    Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):393-399. PubMed ID: 27878431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.